Fora Capital, LLC Iovance Biotherapeutics, Inc. Transaction History

Fora Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$28.67 - $52.59 $381,712 - $700,183	-13,314 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$28.04 - $50.26 $357,790 - $641,317	12,760 Added 2303.25%	13,314 $617,000
Q3 2020 Nov 13, 2020	BUY	$27.75 - $36.3 $15,373 - $20,110	554 New	554 $18 Million
Q2 2020 Aug 14, 2020	SELL	$27.21 - $41.0 $316,942 - $477,568	-11,648 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$19.54 - $38.85 $20,028 - $39,821	-1,025 Reduced 8.09%	11,648 $348,000
Q4 2019 Feb 14, 2020	BUY	$17.95 - $29.41 $227,480 - $372,712	12,673 New	12,673 $350,000

319

243M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $923M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.